Andrew Roberts AM is a Clinical Haematologist at Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Cancer Theme co-Leader at the Walter and Eliza Hall Institute of Medical Research, and the Metcalf Chair of Leukaemia Research at the University of Melbourne. A past president of the Haematology Society of Australia and New Zealand and past Chair of the board of Cancer Council Victoria, he is currently a Director of the Australasian Leukaemia and Lymphoma Group (national clinical trials collaborative) and the Victorian Comprehensive Cancer Centre Alliance, and chairs the Life Saving Drug Program Expert Panel for the Australian government. His laboratory and clinical research pioneered the way for venetoclax, the first in a new class of targeted anti-cancer drug, to become a routine treatment for selected leukaemias. For this work, he and colleagues have received multiple awards, including the 2019 Prime Ministers Prize for Innovation in 2019. Since 2020, he has served as Deputy Editor of Blood, the leading haematology journal. At Peter Mac and Royal Melbourne Hospital he cares for patients undergoing bone marrow stem cell transplants and people with selected blood cancers. Professor Roberts continues to lead laboratory and clinical trials research into new treatments.